Pharmacological treatment of schizophrenia

Abstract

Background: A lack of human and financial resources, as well as effective health systems, leads to a worldwide treatment gap for schizophrenia. the aim of this paper is to propose evidence-based antipsychotics interventions for people with schizophrenia with special focus in low and middle income countries (LAMIC) reality. Method: A comprehensive search was conducted to locate the main clinical trials, reviews and relevant meta-analyses, and a number of the main recent international clinical practice guidelines. Results: First- and second-generation antipsychotics are similarly effective in the acute treatment of psychotic symptoms. in LAMIC, the treatment of choice for medical treatment of psychotic conditions is the group of so-called 'first generation antipsychotics' (FGAs) preferentially delivered in a community-based service model. Conclusions : Although the symptomatic control is essential, it is not the ultimate goal of treatment. the main aim of treatment is to improve functional recovery and social reintegration of patients.